Novo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, according to new research published Friday ...

A major clinical trial showed such promising results that the drug’s maker halted it early. By Dani Blum Dani Blum has reported on Ozempic and similar drugs since 2022. Semaglutide, the compound ...

People taking Ozempic in a multinational trial experienced a 24 percent reduction in risk of death from cardiovascular and kidney disease compared with those who received a placebo. (David J.

The blockbuster diabetes drug Ozempic — also sold as the obesity drug Wegovy — can add another health condition to the list of maladies it alleviates. Researchers presented clinical-trial data ...

CHRISTOPHER SALAS WCVB NEWSCENTER FIVE. ALL RIGHT. THERE IS A NEW STUDY THAT SHOWS THE MAIN INGREDIENT IN OZEMPIC AND WEGOVY, WHICH ALREADY HELP WITH DIABETES AND WEIGHT LOSS. MAY DRACUT RADICALLY ...

Semaglutide medications such as Ozempic can significantly reduce the risk of kidney complications, heart issues and death in people with Type 2 diabetes, according to a study published Friday.

Weight loss jabs can slash the chances of dying from kidney disease by almost a quarter, a world-first study found. Patients given semaglutide – the key ingredient in Ozempic and Wegovy – were ...

Diabetes treatment slows progression of kidney disease and reduces risk of death, study shows Novo Nordisk's diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have ...

Semaglutide, the compound in the blockbuster drugs Ozempic and Wegovy, dramatically reduced the risk of kidney complications, heart issues and death in people with Type 2 diabetes and chronic ...